← The Polylog AI Intelligence Brief
Morning Edition · Wednesday, October 28, 2026Published at 2:21 AM EDT · New York
Claude Produced 17 Lab-Confirmed Scorpion-Toxin Binders From 318,000 Designs, as Small Clinical Models Approach GPT-4 Scores
Anthropic's study showed binding but not neutralization, and the MedJev paper reports 72.5% on MedQA from a model that runs on a laptop.
Anthropic reported that Claude designed protein binders against scorpion neurotoxins while working largely on its own. Claude ran 12 protein-design tools to generate 318,484 candidates in 64 hours and computationally screened 553,052 protei…
Continue the AI Intelligence Brief
Track frontier labs, chips, export controls, model releases, regulation, and AI infrastructure.
- 5 AI intelligence signals a day
- Frontier labs, compute, and chips
- Model releases and AI infrastructure
- Source-grounded analysis with confidence labels
The Global Intelligence Brief stays free.
Part of a tracked trend
AI Moves Into Autonomous Scientific Discovery and Clinical Care
Over the next 3-9 months, AI systems move beyond text tasks into running real scientific experiments and managing clinical care, backed by peer-reviewed and benchmarked evidence of chemist- and physician-level performance.
Townsquare
Start a discussion in Townsquare.
More from this edition
- Anthropic's IPO Filing Shows $16.3 Billion in Half-Year Revenue and Hundreds of Billions in Fixed Compute Contracts
- Moonshot Cuts Cyber Capabilities From Kimi K3.1 Pro Before Releasing Its Weights by November 4
- Axiom Says AI Agents Machine-Checked the Classification of Finite Simple Groups in 24 Days
- Log-To-Leak Paper Shows Poisoned MCP Tool Descriptions Can Make Agents Leak Data After Finishing Their Task
- Google DeepMind Previews Genie 4, a Real-Time World Model That Generates Sound and Dialogue
- EU Governments Back a GDPR Change That Lets Companies Claim Legitimate Interest to Train AI on Personal Data
- OpenAI Pushes GPT-6 Astra Into Oracle's Enterprise Apps While a New Paper Questions Vendor Time-Savings Claims
Comments
0No comments yet.